320 related articles for article (PubMed ID: 9661138)
1. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
2. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
[TBL] [Abstract][Full Text] [Related]
3. Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients.
Pestana M; Faria MS; Oliveira JG; Baldaia J; Santos A; Guerra LE; Soares-da-Silva P
Nephrol Dial Transplant; 1997 Dec; 12(12):2667-72. PubMed ID: 9430869
[TBL] [Abstract][Full Text] [Related]
4. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
[TBL] [Abstract][Full Text] [Related]
5. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
Vieira-Coelho MA; Pestana M; Soares-da-Silva P
Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
[TBL] [Abstract][Full Text] [Related]
6. Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney.
Sampaio-Maia B; Moreira-Rodrigues M; Pestana M
Nephron Physiol; 2006; 103(1):p14-24. PubMed ID: 16352914
[TBL] [Abstract][Full Text] [Related]
7. Heart failure, aging, and renal synthesis of dopamine.
Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
[TBL] [Abstract][Full Text] [Related]
8. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
9. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney.
Vieira-Coelho MA; Serrão P; Guimarães JT; Pestana M; Soares-da-Silva P
Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1033-44. PubMed ID: 11097621
[TBL] [Abstract][Full Text] [Related]
10. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
Vieira-Coelho MA; Hussain T; Kansra V; Serrao MP; Guimaraes JT; Pestana M; Soares-Da-Silva P; Lokhandwala MF
Hypertension; 1999 Oct; 34(4 Pt 1):666-72. PubMed ID: 10523344
[TBL] [Abstract][Full Text] [Related]
11. Renal dopaminergic system in nephrotic syndrome and after remission.
Pestana M; Jardim H; Afonso C; Serrão P; Santos N; Guerra L; Soares-da-Silva P
Nephrol Dial Transplant; 1998 Oct; 13(10):2559-62. PubMed ID: 9794559
[TBL] [Abstract][Full Text] [Related]
12. A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
Armando I; Nowicki S; Aguirre J; Barontini M
Am J Physiol; 1995 Jun; 268(6 Pt 2):F1087-92. PubMed ID: 7611449
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high sodium intake.
Soares-da-Silva P; Vieira-Coelho MA; Pestana M
Br J Pharmacol; 1996 Mar; 117(6):1193-8. PubMed ID: 8882615
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Huang L; Deng M; Zhang S; Fang Y; Li L
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
[TBL] [Abstract][Full Text] [Related]
15. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
[TBL] [Abstract][Full Text] [Related]
16. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
[TBL] [Abstract][Full Text] [Related]
17. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.
Siirtola T; Sonninen V; Rinne UK
Clin Neurol Neurosurg; 1975; 78(2):77-88. PubMed ID: 1222507
[TBL] [Abstract][Full Text] [Related]
19. [An increase in renal dopamine production after the administration of radiographic contrast agents].
Santos J; Araújo V; Moura L; Serrão P; Guerra L; Maciel J; Pestana M
Rev Port Cardiol; 1998 Dec; 17(12):1007-11. PubMed ID: 9973862
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
